Literature DB >> 27620904

High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.

Francisco Martínez1, Alfonso Caro-Llopis1, Mónica Roselló1, Silvestre Oltra1, Sonia Mayo1, Sandra Monfort1, Carmen Orellana1.   

Abstract

BACKGROUND: Intellectual disability is a very complex condition where more than 600 genes have been reported. Due to this extraordinary heterogeneity, a large proportion of patients remain without a specific diagnosis and genetic counselling. The need for new methodological strategies in order to detect a greater number of mutations in multiple genes is therefore crucial.
METHODS: In this work, we screened a large panel of 1256 genes (646 pathogenic, 610 candidate) by next-generation sequencing to determine the molecular aetiology of syndromic intellectual disability. A total of 92 patients, negative for previous genetic analyses, were studied together with their parents. Clinically relevant variants were validated by conventional sequencing.
RESULTS: A definitive diagnosis was achieved in 29 families by testing the 646 known pathogenic genes. Mutations were found in 25 different genes, where only the genes KMT2D, KMT2A and MED13L were found mutated in more than one patient. A preponderance of de novo mutations was noted even among the X linked conditions. Additionally, seven de novo probably pathogenic mutations were found in the candidate genes AGO1, JARID2, SIN3B, FBXO11, MAP3K7, HDAC2 and SMARCC2. Altogether, this means a diagnostic yield of 39% of the cases (95% CI 30% to 49%).
CONCLUSIONS: The developed panel proved to be efficient and suitable for the genetic diagnosis of syndromic intellectual disability in a clinical setting. Next-generation sequencing has the potential for high-throughput identification of genetic variations, although the challenges of an adequate clinical interpretation of these variants and the knowledge on further unknown genes causing intellectual disability remain to be solved. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Intellectual disability; de novo mutation; genetic diseases; sequence analysis

Mesh:

Year:  2016        PMID: 27620904     DOI: 10.1136/jmedgenet-2016-103964

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  37 in total

1.  De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.

Authors:  Daniel Fritzen; Alma Kuechler; Mona Grimmel; Jessica Becker; Sophia Peters; Marc Sturm; Hela Hundertmark; Axel Schmidt; Martina Kreiß; Tim M Strom; Dagmar Wieczorek; Tobias B Haack; Stefanie Beck-Wödl; Kirsten Cremer; Hartmut Engels
Journal:  Hum Genet       Date:  2018-05-23       Impact factor: 4.132

2.  De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.

Authors:  Sandra Jansen; Ilse M van der Werf; A Micheil Innes; Alexandra Afenjar; Pankaj B Agrawal; Ilse J Anderson; Paldeep S Atwal; Ellen van Binsbergen; Marie-José van den Boogaard; Lucia Castiglia; Zeynep H Coban-Akdemir; Anke van Dijck; Diane Doummar; Albertien M van Eerde; Anthonie J van Essen; Koen L van Gassen; Maria J Guillen Sacoto; Mieke M van Haelst; Ivan Iossifov; Jessica L Jackson; Elizabeth Judd; Charu Kaiwar; Boris Keren; Eric W Klee; Jolien S Klein Wassink-Ruiter; Marije E Meuwissen; Kristin G Monaghan; Sonja A de Munnik; Caroline Nava; Charlotte W Ockeloen; Rosa Pettinato; Hilary Racher; Tuula Rinne; Corrado Romano; Victoria R Sanders; Rhonda E Schnur; Eric J Smeets; Alexander P A Stegmann; Asbjørg Stray-Pedersen; David A Sweetser; Paulien A Terhal; Kristian Tveten; Grace E VanNoy; Petra F de Vries; Jessica L Waxler; Marcia Willing; Rolph Pfundt; Joris A Veltman; R Frank Kooy; Lisenka E L M Vissers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2019-01-24       Impact factor: 4.246

3.  Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.

Authors:  Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Anne Dieux; Alexandra Afenjar; Jamal Ghoumid; Bertrand Diebold; Léo Mietton; Audrey Briand-Suleau; Pierre Billuart; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

4.  Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.

Authors:  Keren Machol; Justine Rousseau; Sophie Ehresmann; Thomas Garcia; Thi Tuyet Mai Nguyen; Rebecca C Spillmann; Jennifer A Sullivan; Vandana Shashi; Yong-Hui Jiang; Nicholas Stong; Elise Fiala; Marcia Willing; Rolph Pfundt; Tjitske Kleefstra; Megan T Cho; Heather McLaughlin; Monica Rosello Piera; Carmen Orellana; Francisco Martínez; Alfonso Caro-Llopis; Sandra Monfort; Tony Roscioli; Cheng Yee Nixon; Michael F Buckley; Anne Turner; Wendy D Jones; Peter M van Hasselt; Floris C Hofstede; Koen L I van Gassen; Alice S Brooks; Marjon A van Slegtenhorst; Katherine Lachlan; Jessica Sebastian; Suneeta Madan-Khetarpal; Desai Sonal; Naidu Sakkubai; Julien Thevenon; Laurence Faivre; Alice Maurel; Slavé Petrovski; Ian D Krantz; Jennifer M Tarpinian; Jill A Rosenfeld; Brendan H Lee; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2018-12-20       Impact factor: 11.025

Review 5.  Cohesin subunit RAD21: From biology to disease.

Authors:  Haizi Cheng; Nenggang Zhang; Debananda Pati
Journal:  Gene       Date:  2020-07-17       Impact factor: 3.688

6.  A novel MAP3K7 splice mutation causes cardiospondylocarpofacial syndrome with features of hereditary connective tissue disorder.

Authors:  Silvia Morlino; Marco Castori; Chiara Dordoni; Valeria Cinquina; Graziano Santoro; Paola Grammatico; Marina Venturini; Marina Colombi; Marco Ritelli
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

7.  De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.

Authors:  Anne Gregor; Lynette G Sadleir; Reza Asadollahi; Silvia Azzarello-Burri; Agatino Battaglia; Lilian Bomme Ousager; Paranchai Boonsawat; Ange-Line Bruel; Rebecca Buchert; Eduardo Calpena; Benjamin Cogné; Bruno Dallapiccola; Felix Distelmaier; Frances Elmslie; Laurence Faivre; Tobias B Haack; Victoria Harrison; Alex Henderson; David Hunt; Bertrand Isidor; Pascal Joset; Satoko Kumada; Augusta M A Lachmeijer; Melissa Lees; Sally Ann Lynch; Francisco Martinez; Naomichi Matsumoto; Carey McDougall; Heather C Mefford; Noriko Miyake; Candace T Myers; Sébastien Moutton; Addie Nesbitt; Antonio Novelli; Carmen Orellana; Anita Rauch; Monica Rosello; Ken Saida; Avni B Santani; Ajoy Sarkar; Ingrid E Scheffer; Marwan Shinawi; Katharina Steindl; Joseph D Symonds; Elaine H Zackai; André Reis; Heinrich Sticht; Christiane Zweier
Journal:  Am J Hum Genet       Date:  2018-07-26       Impact factor: 11.025

8.  Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.

Authors:  Angélique Quartier; Hélène Poquet; Brigitte Gilbert-Dussardier; Massimiliano Rossi; Anne-Sophie Casteleyn; Vincent des Portes; Claire Feger; Elsa Nourisson; Paul Kuentz; Claire Redin; Julien Thevenon; Anne-Laure Mosca-Boidron; Patrick Callier; Jean Muller; Gaetan Lesca; Frédéric Huet; Véronique Geoffroy; Salima El Chehadeh; Matthieu Jung; Benoit Trojak; Stéphanie Le Gras; Daphné Lehalle; Bernard Jost; Stéphanie Maury; Alice Masurel; Patrick Edery; Christel Thauvin-Robinet; Bénédicte Gérard; Jean-Louis Mandel; Laurence Faivre; Amélie Piton
Journal:  Eur J Hum Genet       Date:  2017-02-08       Impact factor: 4.246

9.  Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.

Authors:  Xenia Latypova; Marie Vincent; Alice Mollé; Oluwadamilare A Adebambo; Cynthia Fourgeux; Tahir N Khan; Alfonso Caro; Monica Rosello; Carmen Orellana; Dmitriy Niyazov; Damien Lederer; Marie Deprez; Yline Capri; Peter Kannu; Anne Claude Tabet; Jonathan Levy; Emmelien Aten; Nicolette den Hollander; Miranda Splitt; Jagdeep Walia; Ladonna L Immken; Pawel Stankiewicz; Kirsty McWalter; Sharon Suchy; Raymond J Louie; Shannon Bell; Roger E Stevenson; Justine Rousseau; Catherine Willem; Christelle Retiere; Xiang-Jiao Yang; Philippe M Campeau; Francisco Martinez; Jill A Rosenfeld; Cédric Le Caignec; Sébastien Küry; Sandra Mercier; Kamran Moradkhani; Solène Conrad; Thomas Besnard; Benjamin Cogné; Nicholas Katsanis; Stéphane Bézieau; Jeremie Poschmann; Erica E Davis; Bertrand Isidor
Journal:  Am J Hum Genet       Date:  2021-04-02       Impact factor: 11.025

10.  Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.